Correction: DMT alters cortical travelling waves.
Elife November 9, 2020 Andrea Alamia, Christopher Timmermann, David Nutt et al. 7 citations correction
Correction: DMT alters cortical travelling waves.
ISSN 2050-084x
30 papers in the library · 1,122 citations · publishing 2014-2026
Elife November 9, 2020 Andrea Alamia, Christopher Timmermann, David Nutt et al. 7 citations correction
Correction: DMT alters cortical travelling waves.
Elife October 12, 2020 Andrea Alamia, Christopher Timmermann, David Nutt et al. 86 citations
Psychedelic drugs are potent modulators of conscious states and therefore powerful tools for investigating their neurobiology. N,N, Dimethyltryptamine (DMT) can rapidly induce an extremely immersive state of consciousness characterized by vivid and elaborate visual imagery. Here, we investigated the electrophysiological correlates of the DMT-induced altered state from a pool of participants...
Elife October 25, 2018 Katrin H. Preller, Joshua B. Burt, Jie Lisa Ji et al. 416 citations
Background: Lysergic acid diethylamide (LSD) has agonist activity at various serotonin (5-HT) and dopamine receptors. Despite the therapeutic and scientific interest in LSD, specific receptor contributions to its neurobiological effects remain unknown. Methods: We therefore conducted a double-blind, randomized, counterbalanced, cross-over studyduring which 24 healthy human participants received...
Elife April 13, 2015 Ben M Crittenden, Daniel J Mitchell, John Duncan 202 citations
In the human brain, a default mode or task-negative network shows reduced activity during many cognitive tasks and is often associated with internally-directed processes, such as mind wandering and thoughts about the self. In contrast to this task-negative pattern, we show increased activity during a large and demanding switch in task set. Furthermore, we employ multivoxel pattern analysis and...
Elife December 12, 2014 Thu N Huynh, Eric Klann 1 citation
Genetically modified mice shed new light on how ketamine can target NMDA receptors in the brain to reduce the symptoms of depression.